Abbott Laboratories Statistics

Total Valuation

Abbott Laboratories has a market cap or net worth of GBP 165.87 billion. The enterprise value is 171.95 billion.

Market Cap	165.87B
Enterprise Value	171.95B

Important Dates

The last earnings date was Wednesday, January 22, 2025.

Earnings Date	Jan 22, 2025
Ex-Dividend Date	Jan 15, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.06%
Shares Change (QoQ)	-0.09%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.72B

Valuation Ratios

The trailing PE ratio is 15.49.

PE Ratio	15.49
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	23.63
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	16.06
EV / Sales	5.05
EV / EBITDA	21.09
EV / EBIT	31.03
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.38
Debt / EBITDA	1.50
Debt / FCF	n/a
Interest Coverage	31.74

Financial Efficiency

Return on equity (ROE) is 33.99% and return on invested capital (ROIC) is 7.77%.

Return on Equity (ROE)	33.99%
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	7.77%
Revenue Per Employee	293,933
Profits Per Employee	93,905
Employee Count	114,000
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1.43% in the last 52 weeks. The beta is 0.66, so Abbott Laboratories's price volatility has been lower than the market average.

Beta (5Y)	0.66
52-Week Price Change	+1.43%
50-Day Moving Average	115.11
200-Day Moving Average	110.62
Relative Strength Index (RSI)	64.79
Average Volume (20 Days)	28,565

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Abbott Laboratories had revenue of GBP 33.51 billion and earned 10.71 billion in profits. Earnings per share was 6.10.

Revenue	33.51B
Gross Profit	18.57B
Operating Income	5.45B
Pretax Income	5.60B
Net Income	10.71B
EBITDA	8.02B
EBIT	5.45B
Earnings Per Share (EPS)	6.10

Full Income Statement

Balance Sheet

The company has 6.22 billion in cash and 12.02 billion in debt, giving a net cash position of -5.80 billion.

Cash & Cash Equivalents	6.22B
Total Debt	12.02B
Net Cash	-5.80B
Net Cash Per Share	n/a
Equity (Book Value)	31.97B
Book Value Per Share	18.33
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 55.41%, with operating and profit margins of 16.27% and 31.95%.

Gross Margin	55.41%
Operating Margin	16.27%
Pretax Margin	16.72%
Profit Margin	31.95%
EBITDA Margin	23.93%
EBIT Margin	16.27%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 1.77, which amounts to a dividend yield of 1.52%.

Dividend Per Share	1.77
Dividend Yield	1.52%
Dividend Growth (YoY)	7.32%
Years of Dividend Growth	6
Payout Ratio	n/a
Buyback Yield	0.06%
Shareholder Yield	1.58%
Earnings Yield	6.45%
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on June 1, 1998. It was a forward split with a ratio of 2.

Last Split Date	Jun 1, 1998
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a